Business combination

12 Months Ended

Dec. 31, 2025

Disclosure of detailed information about business combination [abstract]

47.	BUSINESS COMBINATION

(1)	Tongyang Life Insurance Co., Ltd.

General

The Group obtained approval from the Financial Services Commission on May 2, 2025, to include a subsidiary, and acquired

77.9

of the interest (excluding treasury stocks;

75.3

including treasury stocks) of Tongyang Life Insurance Co., Ltd. (“Tongyang Life”) on July 1, 2025, thereby obtaining control. The primary purpose of this business combination is to maximize synergy effects among consolidated subsidiaries and strengthen the

non-banking

business portfolio.

From the acquisition date (July 1, 2025) to the end of the current reporting period, Tongyang Life’s operating income and net income reflected in the consolidated statement of comprehensive income amounted to

49,386

million

Won and

43,609

million Won, respectively. Assuming that the acquisition of Tongyang Life had occurred at the beginning of the annual reporting period (January 1, 2025), Tongyang Life’s operating income and net income that would have been recognized in the consolidated statement of comprehensive income are estimated to be 149,439 million Won and 126,021 million Won, respectively.

ii.	Identifiable net assets:


	(Unit: Korean Won in millions)
	Amount
Assets
Cash and cash equivalents		286,417
Financial assets at fair value through profit or loss		5,799,449
Financial assets at fair value through other comprehensive income		21,635,551
Financial assets at amortized cost (*1)		6,544,801
Derivative assets		172,326
Investment properties		426,509
Premises and equipment		115,287
Intangible assets		29,953
Deferred tax assets		130,646
Investments in associates		28,521
Reinsurance contracts assets		578,741
Other assets		53,754

Sub-total		35,801,955


	(Unit: Korean Won in millions)
	Amount
Liabilities
Insurance contract liabilities		28,743,076
Reinsurance contract liabilities		10,900
Investment contract liabilities		3,474,425
Financial liabilities at fair value through profit or loss		256
Financial liabilities at amortized cost		1,100,627
Derivative liabilities		196,317
Provisions		41,393
Other liabilities		35,503

Sub-total		33,602,497

Identifiable Net Assets Fair value (*2)		2,199,458

(*1)

The financial assets measured at amortized cost that were acquired have been estimated at fair value. The contractual gross amount of Tongyang Life’s financial assets measured at amortized cost is KRW 6,547,834 million, and the contractual cash flows that are not expected to be recovered as of the acquisition date are estimated at KRW 90,923 million.

(*2)	The Group measured the identifiable assets and liabilities of the acquiree at their fair values as of the acquisition date for the purpose of allocating the consideration transferred

If, within one year from the acquisition date, new information is obtained about facts and circumstances that existed at the acquisition date requiring adjustments to the amounts recognized at that date, or if additional provisions existing at the acquisition date need to be recognized, such adjustments will be accounted for in the business combination.

iii.	Bargain purchase gain

A bargain purchase gain occurred as the fair value of identifiable net assets exceeded the consideration transferred.


	(Unit: Korean Won in millions)
	Amount
Consideration transferred		1,281,963
Identifiable net assets fair value		2,199,458
Non-controlling interests (*1)		236,994
Hybrid securities (*2)		406,310
Bargain purchase gain (*3)		274,191

(*1)	The non-controlling interests in Tongyang Life acquired during the current period were measured at the fair value based on the closing price at the acquisition date.

(*2)

It is a hybrid securities issued by Tongyang Life and classified as equity, which does not grant rights to a proportionate interest of the acquiree’s identifiable net assets, and was measured at fair value using the Hull-White valuation method with discount rates based on credit ratings, interest rate volatility, and exchange rates as input variables.

(*3)	Included in other non-operating income in the consolidated statement of comprehensive income.

iv.	Business combination costs

The Group incurred costs of 1,972 million Won related to the business combination, including legal fees and due diligence fees, which were recognized as fees and commissions expenses in the consolidated statement of comprehensive income.

v.	Net cash outflows from the business combination


	(Unit: Korean Won in millions)
	Amount
Consideration paid in cash		1,281,963
Cash and cash equivalents acquired		286,417

Less: Total		995,546

(2)	ABL Life Insurance Co., Ltd.

General

The Group obtained approval from the Financial Services Commission on May 2, 2025, to include a subsidiary, and acquired 100% of the interest of ABL Life Insurance Co., Ltd. (“ABL Life”) on July 1, 2025, thereby obtaining control. The primary purpose of this business combination is to maximize synergy effects among consolidated subsidiaries and strengthen the

non-banking

business portfolio.

From the acquisition date (July 1, 2025) to the end of the current reporting period, ABL Life’s operating income and net income reflected in the consolidated statement of comprehensive income amounted to 58,653 million Won and 55,984 million Won, respectively. Assuming that the acquisition of ABL Life had occurred at the beginning of the annual reporting period (January 1, 2025), ABL Life’s operating income and net income that would have been recognized in the consolidated statement of comprehensive income are estimated to be 124,104 million Won and 89,840 million Won, respectively.

2)	Identifiable net assets:


	(Unit: Korean Won in millions)
	Amount
Assets
Cash and cash equivalents		327,090
Financial assets at fair value through profit or loss		5,724,722
Securities at fair value through other comprehensive income		11,300,915
Financial assets at amortized cost (*1)		1,647,554
Derivative assets		31,506
Investment properties		154,006
Premises and equipment		329,899
Intangible assets		36,152
Deferred tax assets		305,354
Reinsurance contracts assets		7,704
Other assets		41,402

Sub-total		19,906,304

Liabilities
Insurance contract liabilities		18,324,194
Reinsurance contract liabilities		125,450
Investment contract liabilities		930
Financial liabilities at fair value through profit or loss		8,239
Financial liabilities at amortized cost		828,081
Derivative liabilities		27,827
Provisions		14,848
Other liabilities		4,970

Sub-total		19,334,539

Identifiable Net Assets Fair value (*2)		571,765

(*1)

The financial assets measured at amortized cost that were acquired have been estimated at fair value. The contractual gross amount of ABL Life’s financial assets measured at amortized cost is KRW 1,670,314 million, and the contractual cash flows that are not expected to be recovered as of the acquisition date are estimated at KRW 25,489 million.

(*2)	The Group measured the identifiable assets and liabilities of the acquiree at their fair values as of the acquisition date for the purpose of allocating the consideration transferred.

Bargain purchase gain

A bargain purchase gain occurred as the fair value of identifiable net assets exceeded the consideration transferred.


	(Unit: Korean Won in millions)
	Amount
Consideration transferred		264,946
Identifiable net assets fair value		571,765
Bargain purchase gain (*)		306,819

(*) Included in other

non-operating

income in the consolidated statement of comprehensive income.

Business combination costs

The Group incurred costs of 301 million Won related to the business combination, including legal fees and due diligence fees, which were recognized as fees and commissions expenses in the consolidated statement of comprehensive income.

Net cash inflows from the business combination


	(Unit: Korean Won in millions)
	Amount
Consideration paid in cash		264,946
Cash and cash equivalents acquired		327,090

Less: Total		62,144